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Abstract  21 
Rapid diagnostic tests (RDTs) have been considered as an ideal alternative for light 22 
microscopy to detect malaria parasites especially in remote areas. The development and 23 
improvement of RDTs is an area of intensive research in the last decade. To date, few 24 
parasite proteins have been targeted in RDTs which are known to have certain 25 
deficiencies and made the researchers to look for other promising candidates to address 26 
this problem. Plasmodium falciparum thioredoxin peroxidase 1 (PfTPx-1) is abundantly 27 
expressed in the cytoplasm of the parasite and well conserved across Plasmodium 28 
species making this antigen a promising target for malaria diagnosis. Several 29 
monoclonal antibodies (mAbs) were produced against PfTPx-1. The binding affinities 30 
of mAbs were measured. Several immunochromatographic tests (ICTs) were developed 31 
using different combination of mAbs. All mAbs showed promising affinities to be used 32 
for diagnosis. The sensitivities of ICTs were evaluated using recombinant PfTPx-1 33 
whose results lead us to the preparation of 4 different ICTs. These tests showed positive 34 
reaction with P. falciparum in vitro culture supernatant indicating the release of PfTPx-1 35 
during schizont rupture. Altogether, these findings suggest that PfTPx-1 is a promising 36 
biomarker to diagnose P. falciparum infection. However, the diagnostic performance of 37 
this antigen should be further validated using clinical samples.  38 
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1. Background 41 
Despite being preventable and treatable, malaria still remains as a major public 42 
health concern in the world with 1,238,000 global deaths in 2010 [1]. Emergence of 43 
drug resistance in the malaria parasite, insecticide resistance among the mosquito 44 
vectors and the unavailability of an efficient vaccine against malaria are important 45 
obstacles for controlling this parasitic disease.  46 
Although parasite/parasite antigen-based diagnosis is increasing, most suspected 47 
cases in endemic areas are treated based on presumptive diagnosis [2]. Prompt and 48 
accurate diagnosis and treatment of the patients with appropriate antimalarial is an 49 
essential component of malaria control and elimination strategies. Therefore, since early 50 
2010, WHO has recommended prompt parasitological confirmation by microscopy or 51 
rapid diagnostic test (RDT) for all suspected malaria patients before starting the 52 
treatment [2]. Malaria RDTs were introduced in early 1990s and recently, they have 53 
greatly enhanced the quality of malaria diagnosis in endemic areas [3]. These RDTs 54 
which are lateral flow immune-chromatographic tests (ICT), detect parasite antigens by 55 
specific monoclonal antibodies (mAbs). Commercial RDTs target one of three antigens 56 
namely histidine rich protein 2 (HRP-2), plasmodial lactate dehydrogenase (pLDH) and 57 
aldolase. Despite high sensitivity and specificity for Plasmodium falciparum infections, 58 
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commercial RDTs have known deficiencies such as variable detection thresholds 59 
especially in low transmission areas [4, 5]. There is a need, therefore, to improve current 60 
diagnostic techniques and to develop RDTs targeting additional antigens to address the 61 
current deficiencies as well as new challenges in malaria control.  62 
     Peroxiredoxin (Prx) is a ubiquitous family of antioxidant enzymes with molecular 63 
size of 20-30 kDa that are present in organisms from all kingdoms [6]. In different 64 
parasites, it is shown that Prxs may be potentially valuable candidates for drugs and 65 
vaccines targets [reviewed by 7]. In addition, Prxs may have diagnostic value for the 66 
detection of Leishmania spp., Echinococcus granulosus, Fasciola gigantica, Taenia spp. 67 
[reviewed by 7] and Schistosoma japonicum [8, 9]. The cytoplasmic Prxs from P. 68 
falciparum, P. vivax and P. knowlesi have been characterized by our group [10, 11, 12]. 69 
It was shown that P. falciparum thioredoxin peroxidase 1 (PfTPx-1) is constitutively 70 
and highly expressed through the erythrocytic cycle [13, 14] making it a promising 71 
candidate as a diagnostic antigen for malaria diagnosis. In this study, we produced 72 
several mAbs against PfTPx-1 and evaluated their potential to be used in RDTs.   73 
 74 
2. Materials and Methods 75 
2.1. Production and selection of mAbs 76 
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Recombinant PfTPx-1, P. vivax TPx-1 (PvTPx-1) and P. knowlesi TPx-1 77 
(PkTPx-1) proteins were expressed as a fusion protein with N-terminal histidine-tag and 78 
purified [11]. mAbs were produced as previously described [15]. Briefly, BALB/c mice 79 
were immunized by rPfTPx-1 and hybridomas were developed by fusion of harvested 80 
splenocytes to SP2/0 myeloma cells. Single step hypoxanthine-aminopterin-thymidine 81 
(HAT) selection using methylcellulose and cloning of hybridoma was performed as 82 
previously described with some modifications [16]. Hybridoma cloning medium 83 
consisted of GIT medium (Nihon Pharmaceutical Co., Tokyo, Japan) containing 5% 84 
fetal bovine serum, 5% BriClone (NICB, Dublin, Ireland), HAT and 1.75% 85 
methylcellulose. Following 7-10 days incubation, hybridoma clones were picked and 86 
grown in wells of 96 well tissue culture microplates and screened using enzyme linked 87 
immunosorbent assay (ELISA) and Western blot. The animal experiments in this study 88 
were carried out in compliance with the Obihiro University of Agriculture and 89 
Veterinary Medicine Guidelines for Animal Experimentation (25-74). 90 
 91 
2.2. Purification of mAbs 92 
Isotyping of mAbs was performed using IsoStrip mouse monoclonal antibody 93 
isotyping kit (Roche Diagnostics, Indianapolis, IN). IgG and IgM mAbs from 94 
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hybridoma culture supernatant were purified using protein G (GenScript, NJ, USA) and 95 
protein L (GenScript, NJ, USA), respectively, according to manufacturer’s instructions. 96 
The purity of the mAbs was evaluated by SDS-PAGE under reducing conditions.  97 
 98 
2.3. Measurement of binding affinities of mAbs by ELISA 99 
The binding affinities of mAbs were determined by measuring the dissociation 100 
constant (Kd) as described before [17]. Briefly, constant amounts of mAbs were 101 
incubated with various concentrations of rPfTPx-1 until the equilibrium was reached. 102 
The mixture of antigen-antibody was then transferred to micro-titer plates previously 103 
coated with rPfTPx-1 and the remaining unsaturated mAbs were measured by indirect 104 
ELISA. Kd was determined using Klotz plot [17].  105 
 106 
2.4. Preparation of immunochromatographic tests 107 
Fifty µg/ml of mAb A1 or E4 (Table 1) was added gently to 1 ml of gold 108 
nanoparticles (BBI Solutions, Cardiff, UK), then mixed and kept for 10 min at room 109 
temperature for the immobilization of antibodies onto the gold nanoparticles’ surfaces 110 
by physical adsorption. After immobilization, 10 μl of 5% (w/v) polyethylene glycol 111 
(PEG) and 100 μl of 10% (w/v) bovine serum albumin (BSA) solution were added to 112 
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block the non-coated gold nanoparticles’ surfaces. After the immobilization and 113 
blocking procedures, gold nanoparticle-conjugated mAb was separated by 114 
centrifugation. The gold nanoparticle-conjugated mAb was pulse-sonicated for a few 115 
seconds and was washed with 1 ml of PBS containing 0.05% (w/v) PEG and 0.5% (w/v) 116 
BSA. After mixing, gold nanoparticle-conjugated mAb was collected by the same 117 
process as described above. After pulse sonication, the gold nanoparticle-conjugated 118 
mAb solution was diluted with the dilution buffer containing 20 mM Tris-HCl (pH: 8.2), 119 
0.05% PEG and 3.5% sucrose to OD520=6. The colloidal gold-conjugated mAb was 120 
dried on a glass fiber and used as conjugate pad. 0.5 mg/ml of goat anti-mouse IgG 121 
(ThermoFisher Scientific, IL, USA) and 1 mg/ml of mAb A1, E4 or D5 (Table 1) were 122 
immobilized on the control and test line, respectively. The running buffer for ICTs was 123 
100 mM Na borate (pH: 8), 1% triton X-100, 1% lactose, 1% casein [18]. 124 
 125 
2.5. Western blot 126 
The in vitro culture supernatant P. falciparum 3D7 strain was centrifuged to 127 
remove cell debris and then concentrated with saturated ammonium sulfate. The culture 128 
supernatant proteins were electrophoretically separated using SDS-PAGE and 129 
transferred onto nitrocellulose membrane. Uninfected human erythrocyte lysate was 130 
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used to check the cross reaction of anti-PfTPx-1 antibodies with human peroxiredoxins. 131 
The membrane was blocked by 5% skim milk and further incubated with mAb and 132 
anti-rPfTPx-1 polyclonal antibody. Bound antibodies were detected using an anti-mouse 133 
IgG horseradish peroxidase linked whole antibody (GE Healthcare, Buckinghamshire, 134 
UK). 135 
 136 
3.  Results 137 
3.1 . Production and screening of mAbs 138 
In this study, 11 different mAbs were produced against PfTPx-1 by screening the 139 
hybridoma clones with ELISA and Western blot. Isotyping showed that 5 mAbs are IgG 140 
and 6 mAbs are IgM with kappa light chains (Table 1). Since TPx-1 is a well conserved 141 
enzyme in Plasmodium spp., we decided to clarify the cross reactivity of established 142 
mAbs with the orthologous molecule of PfTPx-1 in P. vivax (PvTPx-1) and P. knowlesi 143 
(PkTPx-1). Western blot analysis was conducted using recombinant PvTPx-1 144 
(rPvTPx-1) and rPkTPx-1 proteins. As a result, all 6 IgM mAbs bind to rPvTPx-1 and 145 





3.2 . Binding affinities of mAbs 149 
In order to evaluate the potential of mAbs to be used for diagnosis, the binding 150 
affinities of mAbs were determined by measuring the dissociation constant (Kd) using 151 
regression analysis and Klotz plot (Supplementary Fig. S1) [17]. As it could be seen in 152 
table 1, Kd of all mAbs was around 1 or less than 1 nM indicating high affinity for all 153 
mAbs which is comparable with commercially used mAbs for malaria RDTs as well as 154 
previous studies [19, 20].  155 
 156 
3.3 . The evaluation of ICTs targeting PfTPx-1 157 
Using different combination of produced mAbs as colloidal gold-conjugated 158 
and/or test line, several ICTs were developed and their sensitivities were evaluated 159 
using rPfTPx-1. As a result, all IgM mAbs and mAb A4 did not show good sensitivities 160 
(data not shown). Four ICTs showed the highest sensitivities (Fig. 1) using mAb A1 or 161 
E4 as colloidal gold-conjugated and mAb A1, E4 or D5 as test line. These ICTs were 162 
able to detect 0.2-0.5 ng of rPfTPx-1 and were further evaluated by in vitro culture 163 
supernatant. All of them showed positive result when P. falciparum in vitro culture 164 
supernatant was used as sample, indicating the presence of PfTPx-1 in the culture 165 
supernatant. In order to confirm this, Western blot analysis was done by transferring the 166 
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culture supernatant proteins onto nitrocellulose membrane and PfTPx-1 was detected by 167 
specific antibodies. As shown in Figure 2, an approximate 22 kDa band corresponding 168 
to PfTPx-1 was appeared, confirming the presence of PfTPx-1 in the culture supernatant. 169 
Moreover, no reaction was seen with uninfected human erythrocytes lysate.  170 
 171 
4.  Discussion 172 
A prompt and reliable diagnostic system remains to be a challenge for malaria 173 
control. Most of malaria death could be prevented if the patients diagnosed and treated 174 
promptly and accurately. Since the traditional microscopy is cumbersome and requires 175 
experienced technicians, RDTs have been introduced as an ideal alternative for 176 
microcopy. The current commercial RDTs for malaria have known pitfalls such as 177 
genetic diversity and persistence of HRP-2 which made WHO to evaluate the 178 
performance of RDTs [21]. To address this problem, improvement of current RDTs and 179 
evaluation of new target antigens are necessary. A number of alternative diagnostic 180 
targets have been introduced namely dihydrofolate reductase–thymidylate synthase, 181 
heme-detoxification protein, glutamate-rich protein, heat-shock protein 70, 182 
hypoxanthine phosphoribosyl transferase and 1-Cys peroxiredoxin [15, 19, 22, 23]. 183 
In this study, we introduced TPx-1 as a new promising candidate for malaria 184 
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diagnosis. TPx-1 is well conserved across the genus Plasmodium, with 83% amino acid 185 
sequence identity among P. falciparum, P. vivax and P. knowlesi (supplementary Fig. 186 
S2) and PfTPx-1 shares 45 % amino acid identity with human orthologue, Prx1. TPx-1 187 
is constitutively expressed in asexual erythrocytic stages and gametocytes of 188 
Plasmodium suggesting a housekeeping role for this enzyme [14, 24]. PfTPx-1 is a 189 
cytoplasmic peroxiredoxin [13], which reduces and detoxifies hydrogen peroxides 190 
through the action of the redox-active cysteine [25]. Moreover, during the trophozoite 191 
stage, PfTPx-1 is one of the most abundantly expressed proteins in the parasite 192 
cytoplasm, accounts for 0.25 to 0.5% of the total cellular protein [13].  193 
Eleven mAbs were produced against PfTPx-1 by immunizing mice with 194 
recombinant protein and subsequent hybridoma production. All mAbs showed high 195 
affinities (Kd of around 1nM) to be used for diagnostic purposes (Table 1). All IgM 196 
mAbs bind to rPfTPx-1, rPvTPx-1 and rPkTPx-1 while IgG mAbs reacted only with 197 
rPfTPx-1. This indicates that all IgM mAbs possibly target a common epitope in 198 
PfTPx-1, PvTPx-1 and PkTPx-1, while, IgG mAbs possibly target PfTPx-1-specific 199 
epitopes making these mAbs specific for P. falciparum and could be used for diagnosing 200 
this human malaria parasite.  201 
In order to evaluate the combination of two mAbs for detection of PfTPx-1, 202 
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different ICTs were developed and evaluated using rPfTPx-1 (data not shown). IgG1 203 
mAbs showed the highest sensitivities and showed positive results when P. falciparum 204 
in vitro culture supernatant was applied on these tests (Fig. 1). The presence of PfTPx-1 205 
in culture supernatant was further confirmed by Western blot studies (Fig. 2). Since 206 
PfTPx-1 is a cytoplasmic protein and is not associated with the parasite membrane [10], 207 
it might be released upon schizont rupture. Furuta et al, (2008) reported that malarial 208 
TPx-1 is a ligand protein for Toll-like receptor 4 and induces IgE-mediated protection 209 
[26]. They suggested that TPx-1 might be released from the parasite when schizonts are 210 
ruptured or infected erythrocytes are destroyed in the spleen [26].  During asexual 211 
development of P. falciparum in the RBCs, late stages parasites are retained in the 212 
capillary system of various organs which is called sequestration [27]. Since PfTPx-1 213 
might be released during schizont rupture into the circulation, targeting PfTPx-1 may 214 
improve the detection of sequestered parasites which cannot be seen by microscopy.  215 
A key concern regarding to sensitivity of HRP-2-based RDTs is the genetic 216 
variation of this antigen (Supplementary Table S2) in different geographical regions [28, 217 
29, 30]. Besides the genetic diversity, lack of HRP-2 gene in P. falciparum isolates have 218 
been reported from various countries [31, 32, 33], which limits the application of 219 
HRP-2-based RDTs in these regions. PfTPx-1 does not show genetic variation 220 
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(Supplementary Table S2) which is another promising advantage of this antigen for 221 
diagnostic purposes.   222 
Another major concern with RDTs targeting PfHRP-2 is the persistence of this 223 
antigen in the blood for long period after parasite clearance that not only produces false 224 
positive results but also decreases the usefulness of this antigen for drug-susceptibility 225 
testing and patients treatment follow up [reviewed by 34]. Therefore, a positive result of 226 
PfHRP-2-based test may indicate a previous infection and should be confirmed using 227 
other diagnostics such as microscopy, PCR or RDT targeting other antigens [35]. To 228 
further evaluate PfTPx-1 as a diagnostic antigen, it is worthy to determine the half life 229 
of this antigen in the patient’s blood.   230 
 231 
5. Conclusions 232 
Here, we introduced and evaluated PfTPx-1 as a promising candidate for malaria 233 
diagnosis. The abundance and consistent expression of PfTPx-1 in P. falciparum 234 
together with having no genetic diversity makes this antigen a promising target for 235 
malaria diagnosis. Moreover, TPx-1 is well conserved across Plasmodium species and 236 
different from human orthologue. Four different ICTs targeting PfTPx-1 were developed 237 
and were able to detect this antigen in P. falciparum in vitro culture supernatant. The 238 
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release of PfTPx-1 in the culture supernatant was further confirmed by Western blot 239 
studies. Taken together, these findings suggest that TPx-1 is a promising candidate for 240 
malaria diagnosis.  241 
 242 
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Table 1. Dissociation constants of monoclonal antibodies determined by ELISA  369 
mAb* Isotype Kd (nM)# SD¶ 
A1 IgG1 1.21 0.08 
A4 IgG3 0.61 0.11 
E4 IgG1 1.295 0.66 
D5 IgG1 1.225 0.80 
C6 IgG1 0.615 0.09 
F1 IgM 0.96 0.49 
B3 IgM 0.67 0.03 
C4 IgM 0.975 0.69 
A5 IgM 0.89 0.08 
D6 IgM 0.79 0.04 
F8 IgM 0.78 0.08 
* Monoclonal antibodies tested. 370 
# The dissociation constants (Kd) are calculated by Klotz plot [18]. 371 
¶ Standard deviation.   372 
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 Figure captions 373 
Fig. 1. Reactivity of developed immunochromatographic tests with P. falciparum in 374 
vitro culture supernatant. Monoclonal antibodies (mAbs) A1 or E4 was used as 375 
gold conjugate (underlined). mAbs A1, E4 or D5 was used in test line and goat 376 
anti-mouse IgG was used as control line. Lane 1: supernatant of non-infected 377 
culture was used as negative control; lane 2: 10 µl of P. falciparum in vitro 378 
culture supernatant was used.  379 
 380 
Fig. 2. Western blot analysis. Western blot analysis of P. falciparum in vitro culture 381 
supernatant. Culture supernatant and uninfected human erythrocyte lysate proteins 382 
were electrophoretically separated using SDS-PAGE and transferred onto 383 
nitrocellulose membrane. M, Marker. Reactivity of mouse anti-PfTPx-1 384 
polyclonal and monoclonal antibody A1 with culture supernatant (lane 1 and 3, 385 




Table S1. Primers for amplification of P. falciparum TPx-1 (PfTPx-1), P. vivax TPx-1 
(PvTPx-1) and P. knowlesi TPx-1 (PkTPx-1). Start and stop codons are underlined 
and restriction sites are italicized. 
 
Table S2. Total single nucleotide polymorphisms (SNPs) are from 143 P. falciparum 
strains. Source: PlasmoDB database.  
 
Fig. S1. Klotz plot of the binding affinities of mAbs measured by indirect ELISA. 
mAbs incubated with different concentration of rPfTPx-1 until the equilibrium is 
reached and the free mAbs are measured by ELISA. A0: OD in the absence of 
antigen; A: OD in the presence of antigen; a0: antigen concentration (nM). 
 
Fig. S2. Amino acid sequence alignment of PfTPx-1, PvTPx-1 and PkTPx-1. The 
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